Lenmid 25 mg contains Lenalidomide, a thalidomide analog used as part of chemotherapy regimens for certain blood cancers, particularly multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by modifying immune responses, inhibiting the growth of abnormal cells, and restricting blood supply to tumors. The 25 mg strength is commonly used during induction or active phases of treatment under close medical supervision.

• Treats multiple myeloma effectively when combined with dexamethasone or other agents

• Delays progression in myelodysplastic syndromes (MDS) with 5q cytogenetic abnormalities

• Improves survival in mantle cell lymphoma post-relapse

• Has both anti-angiogenic and immune-modulating effects

• Can reduce the need for transfusions in certain blood disorders

• Route: Oral administration with water

• Frequency: Typically once daily as prescribed

• Timing: Same time each day, with or without food

• Handling: Swallow whole; do not break or chew

• Monitoring: Regular lab work required during therapy

• Strength: 25 mg Lenalidomide per capsule

• Common Regimen:

  • For multiple myeloma: 25 mg once daily for 21 days in a 28-day cycle

  • MDS and other conditions may vary

• Adjustments: Based on kidney function and treatment response

• Missed Dose: If under 12 hours late, take it. Otherwise, skip and resume next dose.

• Pregnancy Category X: Strictly contraindicated in pregnancy

• Birth Control: Mandatory for men and women of reproductive age

• Blood Clot Risk: High; anticoagulant prophylaxis may be needed

• Blood Monitoring: Frequent CBCs and liver/kidney function tests required

• Handling Precautions: Do not open or crush capsules

• Common Side Effects:

• Tiredness or drowsiness

• Constipation or diarrhea

• Decreased appetite

• Skin rash

• Serious Side Effects:

• Severe drop in blood cell counts

• Blood clots (deep vein thrombosis or pulmonary embolism)

• Liver or kidney dysfunction

• Increased risk of new cancers (rare)

• Serious allergic reactions

• Seek immediate medical help for signs of blood clots, infections, or allergic reactions.

• Muscle cramps

• Store below 25°C in a cool, dry place

• Keep away from moisture and direct sunlight

• Store in original container, tightly closed

• Keep out of reach of children and pets

Q1. What is Lenmid 25 mg used for?
A: It is primarily used to treat multiple myeloma, MDS with 5q deletion, and relapsed mantle cell lymphoma.

Q2. Can women take Lenmid?
A: Yes, but strict pregnancy prevention measures are required due to severe birth defect risks.

Q3. What are the risks associated with Lenmid 25 mg?
A: Major risks include blood clots, low blood counts, and teratogenicity.

Q4. Is this a long-term medication?
A: Treatment duration depends on disease status, response, and tolerance.

Q5. Should patients avoid certain activities?
A: Yes, activities with a risk of injury or bleeding should be avoided during low platelet counts.